CYP2D6 and breast cancer: The main aim of this study was to investigate the consistency between pharmacy dispensation data and information from medical records on adherence to AET in early breast cancer. We also aimed to assess the consistency between pharmacy dispensation data and medical records on treatment with CYP2D6 inhibitors.